| Title |
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2014
|
| DOI | 10.1002/14651858.cd005441.pub3 |
| Pubmed ID | |
| Authors |
Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud |
| Abstract |
Pegylated interferon (peginterferon) plus ribavirin is the recommended treatment for patients with chronic hepatitis C, but systematic assessment of the effect of this treatment compared with interferon plus ribavirin is needed. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 262 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Spain | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 258 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 42 | 16% |
| Student > Bachelor | 37 | 14% |
| Student > Ph. D. Student | 30 | 11% |
| Researcher | 21 | 8% |
| Student > Doctoral Student | 13 | 5% |
| Other | 52 | 20% |
| Unknown | 67 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 90 | 34% |
| Nursing and Health Professions | 24 | 9% |
| Psychology | 21 | 8% |
| Unspecified | 8 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 39 | 15% |
| Unknown | 73 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2017.
All research outputs
#7,197,398
of 22,747,498 outputs
Outputs from Cochrane database of systematic reviews
#8,772
of 12,315 outputs
Outputs of similar age
#70,278
of 221,024 outputs
Outputs of similar age from Cochrane database of systematic reviews
#180
of 238 outputs
Altmetric has tracked 22,747,498 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.